202 related articles for article (PubMed ID: 18751426)
61. Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer.
Perrone G; Ruffini PA; Catalano V; Spino C; Santini D; Muretto P; Spoto C; Zingaretti C; Sisti V; Alessandroni P; Giordani P; Cicetti A; D'Emidio S; Morini S; Ruzzo A; Magnani M; Tonini G; Rabitti C; Graziano F
Eur J Cancer; 2008 Sep; 44(13):1875-82. PubMed ID: 18617393
[TBL] [Abstract][Full Text] [Related]
62. Active immunotherapy for cancer patients using tumor lysate pulsed dendritic cell vaccine: a safety study.
Ovali E; Dikmen T; Sonmez M; Yilmaz M; Unal A; Dalbasti T; Kuzeyli K; Erturk M; Omay SB
J Exp Clin Cancer Res; 2007 Jun; 26(2):209-14. PubMed ID: 17725100
[TBL] [Abstract][Full Text] [Related]
63. [Combined cell therapy by using dendritic cells, T-cells and NK cells to human polymorphic cancer].
Matsushita N; Kobayashi Y; Tanaka Y; Nakao M; Shimizu K; Takeshita N; Tanigawa K; Aruga A
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1655-8. PubMed ID: 15553674
[TBL] [Abstract][Full Text] [Related]
64. Improvement of Impaired Immunological Status of Patients with Various Types of Advanced Cancers by Autologous Immune Cell Therapy.
Kamigaki T; Ibe H; Okada S; Matsuda E; Tanaka M; Oguma E; Kinoshita Y; Ogasawara S; Ono A; Makita K; Naitoh K; Goto S
Anticancer Res; 2015 Aug; 35(8):4535-43. PubMed ID: 26168498
[TBL] [Abstract][Full Text] [Related]
65. Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease.
Lissoni P; Vigore L; Ferranti R; Bukovec R; Meregalli S; Mandala M; Barni S; Tancini G; Fumagalli L; Giani L
J Biol Regul Homeost Agents; 1999; 13(4):216-9. PubMed ID: 10703945
[TBL] [Abstract][Full Text] [Related]
66. Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer.
Shah CA; Allison KH; Garcia RL; Gray HJ; Goff BA; Swisher EM
Gynecol Oncol; 2008 May; 109(2):215-9. PubMed ID: 18314181
[TBL] [Abstract][Full Text] [Related]
67. [Conventional chemotherapy combined with the repetitive immune cell transfer for patients with refractory advanced gastric cancer].
Toh U; Fujii T; Mishima M; Imaizumi T; Koga A; Yano S; Shirouzu K; Yahara T; Yamana H
Gan To Kagaku Ryoho; 2007 Nov; 34(12):1931-3. PubMed ID: 18219856
[TBL] [Abstract][Full Text] [Related]
68. Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells.
Du L; Xiao X; Wang C; Zhang X; Zheng N; Wang L; Zhang X; Li W; Wang S; Dong Z
Cancer Sci; 2011 Jul; 102(7):1272-80. PubMed ID: 21466615
[TBL] [Abstract][Full Text] [Related]
69. Antitumor effect induced by dendritic cell (DC)-based immunotherapy against peritoneal dissemination of the hamster pancreatic cancer.
Takigawa Y; Akiyama Y; Maruyama K; Sugiyama K; Uchida E; Kosuge T; Ueda M; Kitajima M; Yamaguchi K
Cancer Lett; 2004 Nov; 215(2):179-86. PubMed ID: 15488636
[TBL] [Abstract][Full Text] [Related]
70. Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion.
Morisaki T; Matsumoto K; Kuroki H; Kubo M; Baba E; Onishi H; Tasaki A; Nakamura M; Inaba S; Katano M
Anticancer Res; 2003; 23(6a):4459-65. PubMed ID: 14666734
[TBL] [Abstract][Full Text] [Related]
71. Efficient monocyte-derived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment: application to active immunotherapy.
Royer PJ; Bougras G; Ebstein F; Leveque L; Tanguy-Royer S; Simon T; Juge-Morineau N; Chevallier P; Harousseau JL; Gregoire M
Exp Hematol; 2008 Mar; 36(3):329-39. PubMed ID: 18207305
[TBL] [Abstract][Full Text] [Related]
72. [Anti-CCR4 mAb and regulatory T cells].
Kurose K; Ohue Y; Oka M
Gan To Kagaku Ryoho; 2013 Sep; 40(9):1150-5. PubMed ID: 24047773
[TBL] [Abstract][Full Text] [Related]
73. Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: differential short-term changes on corticosteroids therapy.
Navarro J; Aristimuño C; Sánchez-Ramón S; Vigil D; Martínez-Ginés ML; Fernández-Cruz E; de Andrés C
J Neuroimmunol; 2006 Jul; 176(1-2):153-61. PubMed ID: 16698092
[TBL] [Abstract][Full Text] [Related]
74. Regulatory T cells: from bench to bedside.
Jiang S
Int Immunopharmacol; 2009 May; 9(5):515-7. PubMed ID: 19272465
[TBL] [Abstract][Full Text] [Related]
75. Immunotherapy approaches targeting regulatory T-cells.
Onishi H; Morisaki T; Katano M
Anticancer Res; 2012 Mar; 32(3):997-1003. PubMed ID: 22399623
[TBL] [Abstract][Full Text] [Related]
76. [Dendritic cell vaccine for intrahepatic cholangio cellular carcinoma--a study of relationship between immuno-reaction and clinical outcome].
Kotera Y; Kougen Y; Aruga A; Yamamoto M
Gan To Kagaku Ryoho; 2009 Nov; 36(12):1964-6. PubMed ID: 20037292
[TBL] [Abstract][Full Text] [Related]
77. Long-term intravenous administration of activated autologous lymphocytes for cancer patients does not induce antinuclear antibody and rheumatoid factor.
Yamaguchi T; Bamba K; Kitayama A; Kuroiwa Y; Yoshimatsu K; Shimakawa T; Ogawa K; Sekine T; Shimizu N; Yamamoto K
Anticancer Res; 2004; 24(4):2423-9. PubMed ID: 15330194
[TBL] [Abstract][Full Text] [Related]
78. High levels of regulatory T cells in blood are a poor prognostic factor in patients with diffuse large B-cell lymphoma.
Chang C; Wu SY; Kang YW; Lin KP; Chen TY; Medeiros LJ; Chang KC
Am J Clin Pathol; 2015 Dec; 144(6):935-44. PubMed ID: 26573001
[TBL] [Abstract][Full Text] [Related]
79. Regulatory T cells in gastrointestinal tumors.
Raghavan S; Quiding-Järbrink M
Expert Rev Gastroenterol Hepatol; 2011 Aug; 5(4):489-501. PubMed ID: 21780896
[TBL] [Abstract][Full Text] [Related]
80. The role of regulatory T cells in malignant glioma.
Sonabend AM; Rolle CE; Lesniak MS
Anticancer Res; 2008; 28(2B):1143-50. PubMed ID: 18505050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
